Articles by Chitra Sethi - BioPharm International



Articles by Chitra Sethi

Novartis Opens First Flu Cell-Culture Vaccine Manufacturing Facility in the US

Nov 24, 2009

The Swiss pharmaceutical company Novartis has opened a new vaccine manufacturing facility in Holly Springs, NC.

Genmab to Sell US Plant and Cut 300 Jobs

Nov 9, 2009

In an attempt to save around $60 million annually, the Danish biopharmaceutical company Genmab is planning to sell its manufacturing facility located in Brooklyn Park, MN, and reduce headcount by approximately 300 positions.

Sartorius Opens New Plant in India

Oct 30, 2009

In a ribbon-cutting ceremony held on October 30, 2009, Sartorius (Goettingen, Germany) inaugurated its new plant at the Sartorius Group's location in Bangalore, India.

SAFC Pharma Expands Facility to Bolster Biologics Manufacturing

Oct 15, 2009

SAFC Pharma has announced the completion of an addition to its Carlsbad, CA, facility, which specializes in the process development and manufacturing of viral vaccines and viral therapeutics.

InVitria Launches Animal-Origin Free Transferrin

Sep 18, 2009

Colorado-based InVitria, a division of the biopharmaceutical company Ventria Bioscience, has launched an animal-free recombinant transferrin for use in mammalian cell culture.

FDA Grants Orphan Status to Protalix's Gaucher Disease Treatment

Sep 10, 2009

Protalix BioTherapeutics, Inc. (Carmiel, Israel) gained orphan drug status from the US FDA for prGCD, a development drug for Gaucher?s disease, on September 9. The orphan drug designation for prGCD was granted by the FDA?s Office of Orphan Products Development and comes less than a month after the drug received fast-track designation from the FDA.

Shire Completes NDA for Gaucher's Disease Treatment

Sep 4, 2009

Shire plc (Cambridge, MA) has completed its submission of a new drug application (NDA) for velaglucerase alfa, its enzyme replacement therapy in development for the treatment of Type 1 Gaucher disease, with the US Food and Drug Administration.

Pfizer Unveils $214 Million Biotech Facility in Sweden

Aug 27, 2009

Pharmaceutical giant Pfizer, Inc., (New York, NY) has opened a new 64,600-square-foot biotech plant in Strangnas, Sweden.

Accelerated Approval of GSK's Hiberix Boosts Vaccine Supply

Aug 21, 2009

London-based GlaxoSmithKline?s Hiberix, a haemophilus influenzae Type b (Hib) vaccine, was approved by the US Food and Drug Administration.



Click here